规范模型揭示甲基苯丙胺与氯胺酮使用障碍的异质性脑结构特征
本研究基于1209名健康人构建灰质体积发育规范模型,评估184名甲基苯丙胺使用障碍(MUD)、94名氯胺酮使用障碍(KUD)及220名健康对照的个体偏离。发现MUD和KUD灰质体积偏离高度异质,跨物质极端负偏离主要位于默认模式网络(DMN),个体偏离可区分MUD/KUD与对照并在外部数据集重复。
要点
- MUD和KUD患者灰质体积偏离规范模型高度异质,跨物质极端负偏离集中于DMN。
- 基于个体偏离的机器学习模型可区分MUD/KUD与健康对照,并在外部数据集重复。
- 异常灰质体积轨迹与髓鞘化和神经递质系统等神经生物学特征显著相关。
核心结论
- MUD和KUD的灰质体积偏离规范模型呈现高度个体间异质性,跨物质极端负偏离主要位于默认模式网络(DMN)。
- 个体水平偏离可成功区分MUD和KUD与健康对照,并在外部数据集重复。
- 异常灰质体积轨迹与髓鞘化和神经递质系统等神经生物学特征显著相关。
研究设计与样本
- 使用1209名18-65岁健康个体的T1加权图像建立灰质体积发育规范模型。
- 在来自两个独立站点的184名MUD、94名KUD和220名健康对照中估计规范模型偏离。
- 基于个体偏离分数构建机器学习模型识别SUD风险个体。
主要发现
- 规范模型揭示MUD和KUD个体间灰质体积偏离高度异质。
- 跨物质极端负偏离主要位于默认模式网络(DMN)区域。
- 个体水平偏离可区分MUD和KUD与健康对照,并在外部数据集重复。
- 异常灰质体积轨迹与髓鞘化和神经递质系统等神经生物学特征显著相关。
关键数值与推荐
- 规范模型基于1209名18-65岁健康个体的T1加权图像建立。
- 偏离分析纳入184名MUD、94名KUD和220名健康对照,来自两个独立站点。
临床怎么用
- 个体水平灰质体积偏离可作为区分MUD/KUD与健康对照的潜在神经生物学标记。
- 基于偏离分数的机器学习模型有助于SUD临床风险分层和预防。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Marked interindividual heterogeneity in substance use disorder (SUD) impedes the identification of consistent neuroanatomical alterations, limiting the development of robust markers for clinical risk stratification. We applied a normative modeling framework to explore individual neuroanatomical deviations in individuals with SUD across two distinct substance classes, and assessed their potential for classification and risk prediction. We established a developmental normative model of gray matter volume (GMV) using T1-weighted images from 1209 healthy individuals aged 18-65 years. Deviations from this normative model were then estimated for 184 individuals with methamphetamine use disorder (MUD), 94 with ketamine use disorder (KUD), and 220 healthy controls (HC) collected from two independent sites. Based on these individual deviation scores, a machine learning model was constructed to identify individuals at risk for SUD. The normative model revealed high interindividual heterogeneity in GMV deviations among individuals with MUD and KUD. Cross-substance extreme negative deviations were primarily located in regions of the default mode network (DMN). Notably, individual-level deviations could successfully distinguish both MUD and KUD from HC, and replicated in an external dataset. We further identified significant associations between abnormal GMV trajectories and neurobiological features, particularly myelination and neurotransmitter systems. These findings enhance our understanding of the heterogeneous neurobiology underlying SUD, providing potential neurobiological biomarkers for clinical diagnosis, risk stratification, and prevention.
引用
- Sun Y, Fang Y, Peng P, et al. Heterogeneous structural brain signatures of methamphetamine and ketamine use disorders revealed by normative modeling. Mol Psychiatry. 2026. PMID: 42686998. doi:10.1038/s41380-026-03859-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。